AUTL
USDAutolus Therapeutics plc American Depositary Share
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.520
High
$1.535
Low
$1.400
Volume
2.28M
Company Fundamentals
Market Cap
375.3M
Industry
Biotechnology
Country
United Kingdom
Trading Stats
Avg Volume
3.73M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target
Needham analyst Gil Blum reiterates Autolus Therapeutics with a Buy and maintains $10 price target.
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025
LONDON and GAITHERSBURG, Md., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025
Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with no ICANS or high-grade CRS; 50 million cell dose selected for Phase 2 pivotal
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.